LiverMultiScan™ is a diagnostic aid for liver disease that uses multiparametric Magnetic Resonance Imaging (MRI) to quantify liver tissue. LiverMultiScan is non-invasive and characterizes liver tissue by providing accurate and quantitive measures of liver fat, and correlates of iron, fibrosis and inflammation.
LiverMultiScan technology enables post-processing of MRI data into parametric maps of proton density fat fraction (PDFF), T2* and corrected T1 (cT1).
LiverMultiScan is FDA 510(k) cleared in the U.S. and CE marked by notified body BSI 0086 in Europe to aid clinicians in the diagnosis of liver disorders and abnormalities. It can be used as part of the diagnostic pathway for patients. LiverMultiScan is delivered as a service and does not require any additional hardware or software installation and is standardized across manufacturers and field strengths.
LiverMultiScan imaging protocols have been developed by world-class imaging scientists and clinicians, who have evaluated a broad range of imaging techniques for accuracy, reliability, patient comfort and speed, to create a comprehensive imaging package.